Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid 20% vs Intralipid 20% in long-term parenteral nutrition
2005-002425-31Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Dec 2006
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of SMOFlipid in intestinal failure (IF), sponsored by Fresenius Kabi. Started Dec 2006; status: completed.
02
Drugs
SMOFlipid
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on 2005-002425-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002425-31.